Paper40685652
Androgen receptor expression in triple negative breast cancer: an Algerian population study.
Hedjem A and 10 others. Libyan J Med, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Androgen receptor expression in triple negative breast cancer: an Algerian population study. Papers, record 40685652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40685652
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Androgen receptor expression in triple negative breast cancer: an Algerian population study.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Receptors, Androgen | Major topic |
| Triple Negative Breast Neoplasms | Major topic |
| Humans | |
| Female | |
| Middle Aged | |
| Algeria | |
| Adult | |
| Aged | |
| Biomarkers, Tumor | |
| Survival Rate | |
| Ki-67 Antigen |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24978437 | Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations. | Cancers (Basel) | 2014 | https://conductscience.org/library/papers/24978437 | PubMed |
| 2 | 16938528 | Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes. | Hum Pathol | 2006 | https://conductscience.org/library/papers/16938528 | PubMed |
| 3 | 20586616 | American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). | Arch Pathol Lab Med | 2010 | https://conductscience.org/library/papers/20586616 | PubMed |
| 4 | 23965901 | Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer. | Clin Cancer Res | 2013 | https://conductscience.org/library/papers/23965901 | PubMed |
| 5 | 29327767 | Triple negative breast cancer: A clinico-epidemiological and histopronostic study of 90 cases. | Tunis Med | 2017 | https://conductscience.org/library/papers/29327767 | PubMed |
| 6 | 27426056 | Value of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin. | Sci Rep | 2016 | https://conductscience.org/library/papers/27426056 | PubMed |
| 7 | 19704069 | Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19704069 | PubMed |
| 8 | 28666920 | Neoadjuvant therapy for triple negative and HER2-positive early breast cancer. | Breast | 2017 | https://conductscience.org/library/papers/28666920 | PubMed |
| 9 | 21155040 | Clinicopathlogic and immunohistochemical characteristics of triple negative invasive lobular carcinoma. | Yonsei Med J | 2011 | https://conductscience.org/library/papers/21155040 | PubMed |
| 10 | 21633166 | Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. | J Clin Invest | 2011 | https://conductscience.org/library/papers/21633166 | PubMed |
| 11 | 23031358 | Expression of androgen receptors in triple negative breast carcinomas. | Acta Histochem | 2013 | https://conductscience.org/library/papers/23031358 | PubMed |
| 12 | 20593180 | Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients. | Cancer Chemother Pharmacol | 2011 | https://conductscience.org/library/papers/20593180 | PubMed |
| 13 | 18507821 | Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors. | BMC Cancer | 2008 | https://conductscience.org/library/papers/18507821 | PubMed |
| 14 | 21240988 | Expression of nuclear receptor DAX-1 and androgen receptor in human breast cancer. | J Surg Oncol | 2011 | https://conductscience.org/library/papers/21240988 | PubMed |
| 15 | 25536589 | Outcome of 561 non-metastatic triple negative breast cancer patients: multi-center experience from Turkey. | J BUON | 2014 | https://conductscience.org/library/papers/25536589 | PubMed |
| 16 | 18657139 | Impact of triple negative phenotype on breast cancer prognosis. | Breast J | 2008 | https://conductscience.org/library/papers/18657139 | PubMed |
| 17 | 23373898 | Androgenic pathway in triple negative invasive ductal tumors: its correlation with tumor cell proliferation. | Cancer Sci | 2013 | https://conductscience.org/library/papers/23373898 | PubMed |
| 18 | 24101045 | Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. | J Clin Oncol | 2013 | https://conductscience.org/library/papers/24101045 | PubMed |
| 19 | 23392436 | Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles. | Mod Pathol | 2013 | https://conductscience.org/library/papers/23392436 | PubMed |
| 20 | 18171422 | Triple negative tumours: a critical review. | Histopathology | 2008 | https://conductscience.org/library/papers/18171422 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AR | 367 | PubTator's text mining | https://conductscience.org/library/genes/367 | NCBI Gene |
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| PTPRF | 5792 | PubTator's text mining | https://conductscience.org/library/genes/5792 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40685652
GET https://conductscience.org/api/papers/v1/40685652/references?page=2